ARTICLE | Clinical News
Alibra microsuppository therapy regulatory update
January 4, 2000 8:00 AM UTC
VVUS submitted an NDA to the FDA for Alibra to treat male erectile dysfunction. Alibra consists of alprostadil and prazosin HCl formulated into a microsuppository and delivered via plastic applicator to the urethra. ...